Arizona Public Safety Personnel Retirement System related stories
All articles and analysis
Side Letter: EQT's MAC, GA's covid-19 fund, lenders keep the taps onA MAC clause is invoked in New Zealand, a $5bn covid-19 JV is plotted and a lot of LPs don't know what covid-19 means for their PE fund commitment pace. Here’s today's brief, for our valued subscribers only.
Arizona PSPRS rehires SageView as investment consultantThe US public pension has agreed to a three year contract.
Side Letter: More on Alaska's alts team, Tikehau's new partners, Bain and McKinsey reportsMore details on the restless alternatives team at Alaska's sovereign wealth fund. Plus: notes from Bain's and McKinsey's annual reports and nuggets on Tikehau, AP4 and Blackstone. Here’s today's brief, for our valued subscribers only.
Who were January's biggest capital raisers?Private equity fundraising for the year has kicked off with a bang with at least $41.9bn in final closes already, PEI data show.
Side Letter: PE's Licence to operate, China lockdown, Temasek's approachPE is taking a look at itself and asking questions about transparency, responsibility and its licence to operate. Plus: Temasek on GP relationships, coronavirus in China, regulatory change in Europe and news from 3i and ICG. Here’s today's brief, for our valued subscribers only.
Arizona PSPRS approves $120m commitmentThe US public pension has backed an Asia-focused private equity fund.
Side Letter: PAI's sweet secondaries deal, Partners Group sued, fundraising warsLet's dig deep into a jumbo ice cream deal. Also, Partners Group is accused of breaching an NDA, and has the heat come out of the private debt market? Here’s today's brief, for our valued subscribers only.
MassPRIM: ‘Co-investment is a great tool’Co-investments have given the pension plan a greater insight into its GPs, although finding suitable opportunities is ‘threading a narrow needle’, said director of private equity Michael Bailey.
Arizona PSPRS approves $30m in commitmentsThe US public pension has backed two diversified private equity funds.
Vivo Capital raises $1.43bnThe Palo Alto-based private equity firm closed its ninth healthcare and life sciences fund above its target.